Lv5
1180 积分 2022-05-25 加入
Mavacamten Treatment for Obstructive Hypertrophic Cardiomyopathy
7小时前
待确认
Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy
8小时前
已完结
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
9小时前
已完结
Rhythm vs Rate Control Strategy for Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials
28天前
已完结
Risk of cardiovascular diseases and gastrointestinal bleeding is comparable between celecoxib and non-selective non-steroidal anti-inflammatory drugs in patients with ankylosing spondylitis: a nationwide retrospective cohort study
2个月前
已完结
The Impact of Direct Oral Anticoagulants vs. Warfarin on Stroke Prevention in Elderly Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis
2个月前
已关闭
Cardiovascular Therapeutics at the Crossroads: Pharmacological, Genetic, and Digital Frontiers
3个月前
已完结
2025 ESC Guidelines for the management of myocarditis and pericarditis
4个月前
已完结
皖公网安备34019202002308
